_________________
Pursuant to Section 13 or 15(d) of the Securities Exchange Act Of 1934
Date of report (date of earliest event reported): July 3, 2003
ALARIS MEDICAL SYSTEMS, INC. | ||
(Exact name of registrant as specified in its charter) | ||
Delaware | 1-10207 | 13-3492624 |
(State or other jurisdiction of | (Commission File Number) | (I.R.S. Employer |
incorporation or organization) | Identification Number) | |
|
||
10221 Wateridge Circle San Diego, CA 92121-1579 |
||
(Address, including zip code, of registrants principal executive offices) | ||
|
||
(858) 458-7000 | ||
Registrants telephone number, including area code |
Page 1 of 5
On July 2, 2003, ALARIS Medical Systems, Inc. announced that the underwriters of the Companys recent public offering of common stock have exercised their over-allotment option in full to purchase an additional 1,350,000 shares of common stock. The press release is attached as Exhibit 99.1. |
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. |
ALARIS MEDICAL SYSTEMS, INC. | ||
Date: July 3, 2003 |
/s/DAVID L. SCHLOTTERBECK David L. Schlotterbeck President and Chief Executive Officer |
Exhibit
99.1 Press release of ALARIS Medical Systems Inc., dated July 2, 2003.